Zofran Lawsuit Alleges Drug Exposure Caused Fatal Birth Defects For 8 Day Old Infant

January 07, 2016 – – ZofranLegal.com reports on another lawsuit which was filed by a couple from Kentucky against pharmaceutical giant GlaxoSmithKline regarding the anti-nausea drug they manufacture, Zofran. The suit was filed in the United States District Court for the Eastern District of Kentucky under case number 6:15-cv-00173-GFVT. It was transferred shortly after, however, to Boston and is now under number 1:15-cv-13749. This transfer occurred due to the JPML’s consolidation of all Zofran birth defect lawsuits against GSK.

Lawsuit details show that the baby’s mother was prescribed Zofran while pregnant to help ease the nausea she was experiencing during her first trimester. The first trimester is a common time for women to experience morning sickness. Coincidentally, however, it is also a time when the fetus undergoes much of its initial mouth, heart, and limb tissue development.

The woman’s son was born prematurely just months later at 32 weeks gestation. He weighed 4lbs, 4oz and was 38 centimeters long. Upon birth, he was quickly diagnosed with several serious heart defects, including hypoplastic right heart syndrome. Due to this condition, the right side of his heart was almost completely unformed. After only 8 days of life, the infant boy passed away from cardiac failure due to his congenital heart defects.

The child’s parents claim, like many others who have stepped forward with strikingly similar lawsuits, that fetal exposure to Zofran caused the boy’s defects to form, and therefore also caused his subsequent death.

Plaintiffs in many similar lawsuits often note that Zofran was never approved by the U.S. Food and Drug Administration to treat pregnant women, or even tested for safety on this consumer group. Lawsuits from across the nation have connected fetal Zofran exposure to a variety of defects including cleft lip and palate, atrial septal defect and ventricular septal defect, respiratory distress, transposition of the greater vessels, tetralogy of fallot, clubfoot, and kidney defects.

Zofran birth defect lawsuits, which have now been consolidated in a single court in Boston, Massachusetts, are being overseen by Judge F. Dennis Saylor IV. As they await trial, the attorneys at Monheit Law expect that others will be able to join them. The attorneys are working to ensure that mothers who used Zofran while pregnant and who subsequently gave birth to a child with congenital defects may have the opportunity to fully explore their legal rights. These families and children may be entitled to compensation. Monheit Law is offering free legal consultations for those affected.

To request additional information regarding Zofran birth defect lawsuits, or to ask questions, please contact Michael Monheit, Esq., lead attorney at Monheit Law, by calling (877) 620-8411.

###

Contact ZofranLegal.com:

Michael Monheit
1-877-620-8411
michael@monheit.com
1368 Barrowdale Road, Rydal, PA 19046

ReleaseID: 60007012